Home › Stocks › PRME

Prime Medicine, Inc. (PRME): insider buying, hedge funds & Congress trades

Prime Medicine, Inc. (PRME): 11 insider purchases in the last two years.

Insider buying

FiledInsiderSharesPriceValueType
Aug 5, 2025Alphabet Inc.
TenPercentOwner
1,500,000$3.30$5.0Mno history
Aug 1, 2025Gillis Steven
TenPercentOwner
3,030,300$3.30$10.0Mno history
Aug 1, 2025ARCH Venture Fund XII, L.P.
TenPercentOwner
3,030,300$3.30$10.0Mno history
Aug 1, 2025Nelsen Robert
Director, TenPercentOwner
3,030,300$3.30$10.0Mno history
Jul 1, 2025Liu David R.
TenPercentOwner
21,000$2.52$52.9Kno history
Jun 23, 2025Liu David R.
TenPercentOwner
21,000$2.16$45.4Kno history
Jun 16, 2025Liu David R.
TenPercentOwner
21,000$1.49$31.3Kno history
Jun 12, 2025Liu David R.
TenPercentOwner
21,000$1.60$33.6Kno history
May 22, 2025Reine Allan
Director, Officer
125,000$1.18$147.5Kno history
May 22, 2025Lee Ann L.
Officer
100,000$1.13$113.0Kno history
May 22, 2025Brudnick Richard
Officer
20,000$1.19$23.8Kno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for PRME

Free account. Know when insiders, famous funds or Congress trade it.

Start free